Search

everythinglearnresearchcommunity

for

Search:↓

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Intermediate hair follicles are a better model for studying hair growth and testing hair loss treatments.

The new dutasteride formula can be applied to the skin, may promote hair growth, and has fewer side effects.

Massage increases how deep both rigid and flexible liposomes can go into skin, with flexible ones going deeper, and covering the skin (occlusion) helps rigid ones more.

A new mutation in the hairless gene causes hair loss and skin wrinkling in mice.

Scientists created a gel with nanoparticles to deliver medicine to hair follicles effectively.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Some skin conditions look like acne but are caused by drugs, and they usually get better when the drug is stopped.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.

A woman's hair loss looked like a different condition due to her hairstyle, and treatment stopped further hair loss but didn't regrow hair.

The skin is a complex barrier for drug penetration, but understanding its structure and interactions can improve drug delivery methods.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

A systematic approach is crucial for managing hair loss in women.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Tiny particles carrying roxithromycin can effectively target and deliver the drug to hair follicles without irritation.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Nano-sized lipid particles increase dexamethasone's skin penetration and create a reservoir in the skin layers.